ArticleMedicine2026
Immunoadsorption therapy for chronic inflammatory demyelinating polyradiculoneuropathy in a patient on maintenance hemodialysis: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleChronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare immune-mediated disorder that primarily targets the myelin sheaths of peripheral nerves, leading to limb weakness and sensory disturbances. Established treatments for CIDP include glucocorticoids, intravenous immunoglobulin, and plasma exchange. Immunoadsorption (IA) has emerged as a promising alternative to plasma exchange and has shown favorable efficacy in patients who respond inadequately to first-line therapies. PATIENT CONCERNS: A 37-year-old man presented with progressive numbness and weakness of the limbs. He was a hemodialysis patient with type 2 diabetes mellitus and recurrent buttock furuncles. Subsequent electrophysiological testing indicated demyelinating lesions in 2 peripheral nerves. DIAGNOSES: The diagnosis of CIDP was based on clinical symptoms and electrophysiological examinations.
interventionsIA was selected as the initial monotherapy and long-term maintenance therapy. OUTCOMES: This case demonstrated that IA was well tolerated and associated with sustained clinical improvements. LESSONS: The use of IA for both initial and maintenance therapy may represent an optimal individualized treatment for patients with CIDP undergoing hemodialysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.